Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

3(38%)

Results Posted

50%(2 trials)

Terminated

1(13%)

Phase Distribution

Ph not_applicable

25%

Ph phase_2

38%

Ph phase_3

25%

Ph phase_4

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

3(37.5%)

Phase 3Large-scale testing

2(25.0%)

Phase 4Post-market surveillance

1(12.5%)

N/ANon-phased studies

2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(4)

Terminated(1)

Detailed Status

Completed4

Recruiting2

Terminated1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (37.5%)

Phase 32 (25.0%)

Phase 41 (12.5%)

N/A2 (25.0%)

Trials by Status

terminated113%

completed450%

active_not_recruiting113%

recruiting225%

Recent Activity

3 active trials

Showing 5 of 8

active_not_recruitingphase_3

Psilocybin for Major Depressive Disorder (MDD)

NCT06308653

recruitingphase_2

Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

NCT06349083

recruitingnot_applicable

A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy

NCT06706752

terminatednot_applicable

Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome

NCT03586089

completedphase_2

A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

NCT02371889

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06308653Phase 3

Psilocybin for Major Depressive Disorder (MDD)

Active Not Recruiting

NCT06349083Phase 2

Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

Recruiting

NCT06706752Not Applicable

A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemotherapy

Recruiting

NCT03586089Not Applicable

Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome

Terminated

NCT02371889Phase 2

A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers

Completed

NCT01050348Phase 4

To Investigate the Role of Upstream High Dose Statin in STEMI

Completed

NCT00183196Phase 3

Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone

Completed

NCT00690716Phase 2

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8